SoftBank in Investment Talks With Chinese mRNA Vaccine Firm Abogen – Sources

HONG KONG/BEIJING — Chinese mRNA vaccine developer Suzhou Abogen Biosciences is in talks with Japan’s SoftBank and other investors to raise $300 million-$400 million, people familiar with the matter said. Read More